Filter Results:
(1,022)
Show Results For
- All HBS Web (1,022)
- Faculty Publications (769)
Show Results For
- All HBS Web (1,022)
- Faculty Publications (769)
- January 2011 (Revised September 2011)
- Case
Caterpillar, Inc. (A)
By: David F. Hawkins
2010 Healthcare Reform Act eliminates Medicare Part D subsidy and Caterpillar recognizes a $100 million change. View Details
Keywords: Information Infrastructure; Governing Rules, Regulations, and Reforms; Employment; Cost vs Benefits; Forecasting and Prediction; Change Management; Asset Management; Financial Strategy; Activity Based Costing and Management; Business or Company Management; Technology Industry; Manufacturing Industry; United States
Hawkins, David F. "Caterpillar, Inc. (A)." Harvard Business School Case 111-031, January 2011. (Revised September 2011.)
- 15 Apr 2011
- Conference Presentation
Lords of the Harvest: Reputation Concerns and Regulatory Approval of Genetically Modified Organisms
By: Shon R. Hiatt
- 10 May 2011
- Conference Presentation
Lords of the Harvest: Reputation Concerns and Regulatory Approval of Genetically Modified Organisms
By: Shon R. Hiatt
- 1976
- Chapter
Reflections on the State of Accounting Research and the Regulation of Accounting
By: Michael Jensen
Jensen, Michael. "Reflections on the State of Accounting Research and the Regulation of Accounting." In Conflicts and Compromises in Financial Reporting, edited by John C. Burton.Stanford Lectures in Accounting. Palo Alto, CA: Stanford Graduate School of Business, 1976.
- Article
The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in U.S. Health Care Markets
By: Leemore S. Dafny
This article describes potential regulatory and legislative reforms to assist antitrust enforcement agencies in halting anticompetitive acquisitions and practices, and preserving and promoting competition in health care markets. View Details
Keywords: Health Care and Treatment; Markets; Competition; Governing Rules, Regulations, and Reforms
Dafny, Leemore S. "The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in U.S. Health Care Markets." Promarket (June 10, 2021).
- 2009
- Chapter
Self-regulatory Institutions for Solving Environmental Problems: Perspectives and Contributions from the Management Literature
By: Andrew A. King and Michael W. Toffel
Scholars of management have long considered how institutions can help resolve market imperfections and thereby improve human welfare. Most previous research has emphasized the use of for-profit firms. Such institutions cannot effectively address many environmental... View Details
Keywords: For-Profit Firms; Investment; Governing Rules, Regulations, and Reforms; Corporate Social Responsibility and Impact; Environmental Sustainability; Competitive Advantage
King, Andrew A., and Michael W. Toffel. "Self-regulatory Institutions for Solving Environmental Problems: Perspectives and Contributions from the Management Literature." Chap. 4 in Governance for the Environment: New Perspectives, edited by Magali Delmas and Oran Young, 98–115. Cambridge University Press, 2009.
- September 2004 (Revised April 2005)
- Case
U.S. Market Framework for Gasoline, The: Individual Incentives and Societal Goals in Global Markets
By: Bruce R. Scott and Edward Murphy
Traces the role of gasoline taxes in financing U.S. highways and the use of regulations to increase fuel economy to show how and why the U.S. market framework for gasoline is so different from that in Europe. Focuses on whether the U.S. tax should be raised, as... View Details
- 23 Jul 2024
- In Practice
The New Rules of Trade with China: Navigating Tariffs, Turmoil, and Opportunities
economy. Over the last decade, we have seen the Chinese Communist Party’s (CCP) involvement in corporate governance grow significantly as a shareholder and through political View Details
- 2009
- Working Paper
Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
By: Arthur Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Health Testing and Trials; Power and Influence; Competitive Strategy; Pharmaceutical Industry; European Union; Germany; United States
Daemmrich, Arthur. "Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location." Harvard Business School Working Paper, No. 09-118, April 2009.
- December 2004
- Article
Old Rules and New Realities: Corporate Tax Policy in a Global Setting
By: Mihir A. Desai and James R. Hines Jr.
Desai, Mihir A., and James R. Hines Jr. "Old Rules and New Realities: Corporate Tax Policy in a Global Setting." National Tax Journal 57, no. 4 (December 2004): 937–960.
- Article
Lords of the Harvest: Symbolic Signaling and Regulatory Approval of Genetically Modified Organisms
By: Shon R. Hiatt and Sangchan Park
Hiatt, Shon R., and Sangchan Park. "Lords of the Harvest: Symbolic Signaling and Regulatory Approval of Genetically Modified Organisms." Academy of Management Annual Meeting Proceedings (2010).
- 02 May 2023
- What Do You Think?
How Should Artificial Intelligence Be Regulated—if at All?
(iStockphoto/Rost-9D) Artificial intelligence (AI) is the topic of the moment in circles ranging from science to business to religion. Its potential and implications are driven home when you see robot soccer players improve their game to... View Details
- December 2020
- Article
Unwanted Attention: Swiss Multinationals and the Creation of International Corporate Guidelines in the 1970s
By: Sabine Pitteloud
During the last decade, we have seen an increased opposition to globalization. Within this wave of criticism, firms and more specifically multinational corporations have been major targets, accused of multiple wrongdoings, such as social dumping, fiscal evasion, job... View Details
Keywords: Multinationals; Guidelines; Lobbying; Business History; Multinational Firms and Management; Governing Rules, Regulations, and Reforms; Global Range; Switzerland
Pitteloud, Sabine. "Unwanted Attention: Swiss Multinationals and the Creation of International Corporate Guidelines in the 1970s." Special Issue on Multinational Corporations and the Politics of International Trade. Business and Politics 22, no. 4 (December 2020).
- August 2002 (Revised December 2003)
- Case
Italy: A New Commitment to Growth
By: Richard H.K. Vietor and Rebecca Evans
Examines Italy's efforts to comply with the Maastricht Treaty and become integrated with Europe in the European Union. By 2002, Italy has achieved macroeconomic stability, but slow growth threatens the country's future competitiveness. Prime Minister Silvio Berlusconi... View Details
Keywords: Macroeconomics; Economic Growth; Competitive Strategy; Integration; Governing Rules, Regulations, and Reforms; Policy; Government and Politics; Globalized Economies and Regions; International Relations; Alliances; Italy; European Union
Vietor, Richard H.K., and Rebecca Evans. "Italy: A New Commitment to Growth." Harvard Business School Case 703-007, August 2002. (Revised December 2003.)
- 19 Sep 2017
- Working Paper Summaries
An Invitation to Market Design
.ExternalClass535E8B0AB65740BCB51D3AB82FC0F8CE p.MsoNormal, .ExternalClass535E8B0AB65740BCB51D3AB82FC0F8CE li.MsoNormal, .ExternalClass535E8B0AB65740BCB51D3AB82FC0F8CE div.MsoNormal... View Details
- 2023
- Working Paper
Procedural Burden and Patterns in the Monetization of Regulatory Benefits Across the Federal Regulatory State
By: Elliot Stoller
When do federal agencies provide monetized estimates of regulatory benefits during the regulatory development and review process? Using an original dataset with information on nearly all major rules and their respective regulatory impact assessments between... View Details
Keywords: Governing Rules, Regulations, and Reforms; Policy; Government and Politics; Equality and Inequality
Stoller, Elliot. "Procedural Burden and Patterns in the Monetization of Regulatory Benefits Across the Federal Regulatory State." Harvard Business School Working Paper, No. 23-068, May 2023.
- summer 2008
- Article
Corporate Social Responsibility Through an Economic Lens
By: Forest L. Reinhardt, Robert N. Stavins and Richard H.K. Vietor
Business leaders, government officials, and academics are focusing considerable attention on the concept of "corporate social responsibility" (CSR), particularly in the realm of environmental protection. Beyond complete compliance with environmental regulations, do... View Details
Keywords: Profit; Governance Compliance; Governing Rules, Regulations, and Reforms; Corporate Social Responsibility and Impact; Business and Shareholder Relations; Environmental Sustainability
Reinhardt, Forest L., Robert N. Stavins, and Richard H.K. Vietor. "Corporate Social Responsibility Through an Economic Lens." Review of Environmental Economics and Policy 2, no. 2 (summer 2008).
- November 2002 (Revised June 2003)
- Case
China's Rural Leap Forward
By: Bruce R. Scott and Jamie Matthews
Collectively owned township and village enterprises (TVEs) played a pivotal role in China's rapid growth during the 1980s and 1990s. Although they originated in the policies and institutions of the Maoist era, TVEs thrived only after Deng Xiaoping's economic reforms... View Details
Keywords: Business and Government Relations; Public Sector; Public Ownership; Development Economics; Governing Rules, Regulations, and Reforms; Macroeconomics; Emerging Markets; China
Scott, Bruce R., and Jamie Matthews. "China's Rural Leap Forward." Harvard Business School Case 703-024, November 2002. (Revised June 2003.)
- 2024
- Working Paper
HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how a diverse cast of characters, including public health organizations, research laboratories, for-profit healthcare companies, activists, and regulators, rolled back the outbreak of HIV/AIDS in just fifteen years. Moreover, as the case... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-007, July 2019. (Revised May 2024.)
- 2022
- Article
Regulatory Treatment of Changes in Fair Value and the Composition of Banks' Investment Portfolios
By: Michael Iselin, Jung Koo Kang and Joshua Madsen
In their implementation of Basel III, U.S. bank regulators are again including changes in the fair value of available-for-sale (AFS) debt securities in Tier 1 capital, but only for the largest U.S. banks. This paper investigates a potential impact of expanding this... View Details
Keywords: Fair Value Accounting; SFAS 115; Basel III; Governing Rules, Regulations, and Reforms; Banks and Banking; Debt Securities; Credit; Risk and Uncertainty; Investment Portfolio; Decision Making; Banking Industry; United States
Iselin, Michael, Jung Koo Kang, and Joshua Madsen. "Regulatory Treatment of Changes in Fair Value and the Composition of Banks' Investment Portfolios." Journal of Financial Reporting 7, no. 1 (2022): 123–143.